APA (7th ed.) Citation

Packard, C., Taskinen, M., Björnson, E., Matikainen, N., Söderlund, S., Andersson, L., . . . Borén, J. (2025). Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans. Atherosclerosis (00219150), 404, N.PAG. https://doi.org/10.1016/j.atherosclerosis.2025.119166

Chicago Style (17th ed.) Citation

Packard, C.J, M.R Taskinen, E. Björnson, N. Matikainen, S. Söderlund, L. Andersson, M. Adiels, and J. Borén. "Genetically Determined Increase in Apolipoprotein C-III (APOC3 Gain-of-function) Delays Very Low-density Lipoprotein Clearance in Humans." Atherosclerosis (00219150) 404 (2025): N.PAG. https://doi.org/10.1016/j.atherosclerosis.2025.119166.

MLA (9th ed.) Citation

Packard, C.J, et al. "Genetically Determined Increase in Apolipoprotein C-III (APOC3 Gain-of-function) Delays Very Low-density Lipoprotein Clearance in Humans." Atherosclerosis (00219150), vol. 404, 2025, p. N.PAG, https://doi.org/10.1016/j.atherosclerosis.2025.119166.